cytarabine and e 3330
cytarabine has been researched along with e 3330 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Broxmeyer, HE; Hangoc, G; Kelley, MR; Rohrabaugh, SL | 1 |
Other Studies
1 other study(ies) available for cytarabine and e 3330
| Article | Year |
|---|---|
Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro.
Topics: Animals; Benzoquinones; Cell Cycle; Cell Cycle Proteins; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; DNA-(Apurinic or Apyrimidinic Site) Lyase; Female; Haploinsufficiency; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Immunosuppressive Agents; Mad2 Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Oxygen; Propionates | 2011 |